Danaher, Cryoport, Sartorius win Buy as Guggenheim expands bioprocessing coverage

New York Stock Exchange, Wall st, New York, USA

Matteo Colombo

Guggenheim Partners expanded its coverage on the bioprocessing industry on Thursday, granting Buy recommendations for Danaher (NYSE:DHR), Cryoport (NASDAQ:CYRX), and Sartorius (OTCPK:SARTF) and a Neutral rating for Maravai LifeSciences (NASDAQ:MRVI).

Analyst Subbu Nambi projected a high-single-digit revenue growth for the

Leave a Reply

Your email address will not be published. Required fields are marked *